Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumihiro Taguchi

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Intervirology|May 8, 2009
Development of a chimeric DNA-RNA hammerhead ribozyme targeting SARS virusAkiko Fukushima, Noboru Fukuda, Yimu Lai, et al.
Microbiology and Immunology|April 3, 2008
Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in miceYasushi Ami, Noriyo Nagata, Kazuya Shirato, et al.
The American Journal of Pathology|May 10, 2008
Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young miceNoriyo Nagata, Naoko Iwata, Hideki Hasegawa, et al.
Cancer|May 10, 2002
Clinical significance of telomerase activity in multiple myelomaMotoaki Shiratsuchi, Koichiro Muta, Yasunobu Abe, et al.
Biochemical and Biophysical Research Communications|April 11, 2009
Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epitheliumKazutaka Terahara, Masato Yoshida, Fumihiro Taguchi, et al.
Journal of Virology|September 2, 2016
Intracerebral Inoculation of Mouse-Passaged Saffold Virus Type 3 Affects Cerebellar Development in Neonatal MiceOsamu Kotani, Tadaki Suzuki, Masaru Yokoyama, et al.
Virology|May 9, 2006
Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIsKoji Ishii, Hideki Hasegawa, Noriyo Nagata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2002
[Vitamin K2 therapy for myelodysplastic syndrome]Yasunobu Abe, Koichiro Muta, Nobuhisa Hirase, et al.
Plos One|February 2, 2016
Neuropathogenicity of Two Saffold Virus Type 3 Isolates in Mouse ModelsOsamu Kotani, Asif Naeem, Tadaki Suzuki, et al.
Journal of Virology|April 23, 2010
Role of mouse hepatitis virus (MHV) receptor murine CEACAM1 in the resistance of mice to MHV infection: studies of mice with chimeric mCEACAM1a and mCEACAM1bAsuka Hirai, Nobuhisa Ohtsuka, Toshio Ikeda, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Intervirology|May 8, 2009
Development of a chimeric DNA-RNA hammerhead ribozyme targeting SARS virusAkiko Fukushima, Noboru Fukuda, Yimu Lai, et al.
Microbiology and Immunology|April 3, 2008
Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in miceYasushi Ami, Noriyo Nagata, Kazuya Shirato, et al.
The American Journal of Pathology|May 10, 2008
Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young miceNoriyo Nagata, Naoko Iwata, Hideki Hasegawa, et al.
Cancer|May 10, 2002
Clinical significance of telomerase activity in multiple myelomaMotoaki Shiratsuchi, Koichiro Muta, Yasunobu Abe, et al.
Biochemical and Biophysical Research Communications|April 11, 2009
Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epitheliumKazutaka Terahara, Masato Yoshida, Fumihiro Taguchi, et al.
Journal of Virology|September 2, 2016
Intracerebral Inoculation of Mouse-Passaged Saffold Virus Type 3 Affects Cerebellar Development in Neonatal MiceOsamu Kotani, Tadaki Suzuki, Masaru Yokoyama, et al.
Virology|May 9, 2006
Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIsKoji Ishii, Hideki Hasegawa, Noriyo Nagata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2002
[Vitamin K2 therapy for myelodysplastic syndrome]Yasunobu Abe, Koichiro Muta, Nobuhisa Hirase, et al.
Plos One|February 2, 2016
Neuropathogenicity of Two Saffold Virus Type 3 Isolates in Mouse ModelsOsamu Kotani, Asif Naeem, Tadaki Suzuki, et al.
Journal of Virology|April 23, 2010
Role of mouse hepatitis virus (MHV) receptor murine CEACAM1 in the resistance of mice to MHV infection: studies of mice with chimeric mCEACAM1a and mCEACAM1bAsuka Hirai, Nobuhisa Ohtsuka, Toshio Ikeda, et al.
Pageof 7